title: Porphyria cutanea tarda affecting a rheumatoid arthritis patient treated with methotrexate: association or coincidence?
abstract: We describe the case of a 44-yr-old woman, suffering from rheumatoid arthritis for 15 yr, who developed porphyria cutanea tarda while being treated with methotrexate. The cutaneous lesions healed and the metabolic anomalies improved after a few months, despite continuing the treatment.
authors.affiliation: Department of Rheumatology, Hôpital Cochin, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Chalem
authors.forename: A M
authors.initials: AM
authors.lastname: Ghnassia
authors.forename: Y
authors.initials: Y
authors.lastname: Nordmann
authors.forename: C J
authors.initials: CJ
authors.lastname: Menkes
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism; D008727:Methotrexate / Q000009:adverse effects*; D017119:Porphyria Cutanea Tarda / Q000139:chemically induced* / Q000145:classification / Q000378:metabolism
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate